About the Authors

Marijke van Rikxoort

Affiliation Institut für Medizinische Virologie, Klinikum der Johann Wolfgang Goethe-Universität, Frankfurt am Main, Germany

Martin Michaelis

Current address: School of Biosciences, University of Kent, Canterbury, United Kingdom

Affiliation Institut für Medizinische Virologie, Klinikum der Johann Wolfgang Goethe-Universität, Frankfurt am Main, Germany

Markus Wolschek

Affiliation AVIR Green Hills Biotechnology, Vienna, Austria

Thomas Muster

Affiliation AVIR Green Hills Biotechnology, Vienna, Austria

Andrej Egorov

Affiliation AVIR Green Hills Biotechnology, Vienna, Austria

Joachim Seipelt

Affiliation AVIR Green Hills Biotechnology, Vienna, Austria

Hans Wilhelm Doerr

Affiliation Institut für Medizinische Virologie, Klinikum der Johann Wolfgang Goethe-Universität, Frankfurt am Main, Germany

Jindrich Cinatl Jr

Cinatl@em.uni-frankfurt.de

Affiliation Institut für Medizinische Virologie, Klinikum der Johann Wolfgang Goethe-Universität, Frankfurt am Main, Germany

Competing Interests

AVIR Green Hills Biotechnology is a privately held biopharmaceutical company based in Vienna (Austria) that develops and commercializes novel influenza vaccines, and novel therapeutics against infectious diseases and cancer. The most advanced product of AVIR is deltaFLU, an intranasal vaccine against influenza which is in Phase II clinical trials. MW, TM, AE and JS were employees of AGHB at the time of study. TM, JS and AE are shareholders of AVIR, TM is CEO/CSO. IPR rights related to this manuscript are covered by patent rights from AVIR Green Hills. In adherence to the PLoS guidelines, AVIR Green Hills will make freely available any materials and information described in the publication that are reasonably requested by others for the purpose of academic, non-commercial research. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: MvR MM MW JC TM JS AE HWD. Performed the experiments: MvR MW. Analyzed the data: MvR MM TM JS JC MW. Contributed reagents/materials/analysis tools: MW JS TM AE HWD. Wrote the paper: MvR MM HWD.